Screener
UroGen Pharma URGN Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Adjustments to reconcile net loss to net cash from operating activities: | ||
| Depreciation and amortization | 153 | 152 |
| Accrued financing on prepaid forward obligation | 2,050 | 123 |
| Accretion on marketable securities | (250) | (1,640) |
| Share-based compensation | 9,958 | 5,802 |
| Amortization of discount on long-term debt | 1,178 | 774 |
| Amortization of right-of-use assets | 1,167 | 941 |
| Acquisitions of IPR&D | — | 3,128 |
Item 1. Financial Statements.
FAQ
- What is UroGen Pharma's accretion (amortization) of discounts and premiums, investments?
- UroGen Pharma (URGN) reported accretion (amortization) of discounts and premiums, investments of $276K in Q2 2026.
- How has UroGen Pharma's accretion (amortization) of discounts and premiums, investments changed year-over-year?
- UroGen Pharma's accretion (amortization) of discounts and premiums, investments decreased by 68.1% year-over-year, from $866K to $276K.
- What is the long-term trend for UroGen Pharma's accretion (amortization) of discounts and premiums, investments?
- Over 4 years (2021 to 2025), UroGen Pharma's accretion (amortization) of discounts and premiums, investments has grown at a 40.1% compound annual growth rate (CAGR), from -$486K to $1.88M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- Reflects the non-cash adjustment to the carrying value of investment securities resulting from the amortization of premiums or the accretion of discounts. This adjustment aligns the book value of the investment portfolio with its effective interest rate over the holding period.
Ask your AI about UroGen Pharma's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude